Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qi-Shen Yi-Qi dropping pill for convalescent acute myocardial infarction with qi deficiency and blood stasis syndrome
ChiCTR2000029136Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Qishenyiqi Dripping Pills in myocardial infarction (MI) (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Scale-based assessment, Two-dimensional echocardiogram and 1 more. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
Qishenyiqi Dripping Pills
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2000029136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029136.